Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
|
|
- Darcy Lester
- 6 years ago
- Views:
Transcription
1 NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective For the most recent list of drugs, information on obtaining a coverage determination or exception, or other questions, please contact the Presbyterian Customer Service Center. You can reach them Monday through Friday from 7:00 a.m. to 6:00 p.m. Phone: (505) or TTY: 711 Online: Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 01/15/2018 Aliqopa (copanlisib HCL for IV solution) 60 mg vial 01/15/2018 Alphagan P (brimonidine tartrate) 0.1% ophthalmic solution 01/15/2018 Aristada (aripiprazole lauroxil) 441 mg, 662 mg, 882 mg, and 1064 mg extended release suspension for IM injection Formulary addition MB, PA ST requirement added Tier 2, ST brimonidine tartrate 0.2% ophthalmic solution PA requirement removed Tier 4, SP 01/15/2018 Austedo (deutetrabenazine) 6 mg, 9 mg, 12 mg tablets MPC Page 1 of 12 Updated 04/30/18
2 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 01/15/2018 Benlysta (belimumab) for injection for subcutaneous use 200 mg/ml single-dose prefilled autoinjector and single-dose prefilled syringe 01/15/2018 Besponsa (inotuzumab ozogamicin) injection for IV infusion, 0.9 mg singledose vial 01/15/2018 fenofibrate (generic for Tricor ) 48 mg and 145 mg tablets 01/15/2018 guanfacine ER tablets (generic for Intuniv ) 1 mg, 2 mg, 3 mg, 4 mg, SP Formulary addition MB, PA Formulary addition Tier 1 Formulary addition Tier 1, QL 01/15/2018 Humulin R U-500 (insulin human injection) Tier change Moved from Tier 3 to Tier 4 Tier 4, ST, QL 01/15/2018 Kisqali Femara Co-Pack (ribociclib; letrozole) 200/2.5 mg tablets MPC Page 2 of 12 Updated 04/30/18
3 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 01/15/2018 Lynparza (olaparib) 100 mg and 150 mg tablets 01/15/2018 Restasis MultiDose (cyclosporine ophthalmic emulsion) 0.05% 5.5 ml multidose bottle 01/15/2018 tetrabenazine (generic for Xenazine ) 12.5 mg and 25 mg tablets 03/01/2018 Alecensa (alectinib) 150 mg capsules Formulary addition Tier 3, PA, QL, SP 03/01/2018 alfuzosin extended-release (generic for Uroxatral) 10 mg tablets 03/01/2018 armodafinil (generic for Nuvigil) 50 mg, 200 mg, and 250 mg tablets Tier change (moved from Tier 3 to Tier 1) Tier change (moved from Tier 3 to Tier 1) 150 mg tablets removed from formulary Tier 1, QL Tier 1, PA, QL (50 mg, 200 mg, and 250 mg tablets only) 03/01/2018 Bydureon BCISE (exenatide extended-release) injectable suspension 2 mg/0.85 ml auto-injector Formulary addition Tier 2, ST, QL MPC Page 3 of 12 Updated 04/30/18
4 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 03/01/2018 Calquence (acalabrutinib) 100 mg capsules 03/01/2018 Fiasp (insulin aspart injection) 100 units/ml, 10 ml vial and 3 ml FlexTouch pen 03/01/2018 glatiramer acetate 40 mg/ml (generic for Copaxone 40 mg/ml) 03/01/2018 Heplisav-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] Solution for intramuscular injection 03/01/2018 Jeluca (dolutegravir and rilpivirine) mg tablets 03/01/2018 KedRAB Rabies Immune Globulin (Human) Solution for intramuscular injection Formulary addition Tier 2, QL Formulary addition Tier 4, ST, QL, SP Glatopa 20 mg/ml (glatiramer acetate) Tier 4, QL, SP Formulary addition $0, QL, AL Formulary addition Tier 4, QL Formulary addition MB 03/01/2018 modafinil (generic for Provigil) 100 mg and 200 mg talets Tier change (moved from Tier 4 to Tier 1) Tier 1, PA, QL 03/01/2018 Ocrevus (ocrelizumab) 30 mg/ml intravenous solution Specialty Pharmacy mandated MB, PA, SP MPC Page 4 of 12 Updated 04/30/18
5 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 03/01/2018 QVAR RediHaler (beclomethasone dipropionate HFA) 40 mcg/actuation and 80 mcg/actuation breath activated inhalation aerosol Formulary addition Tier 3, PA Asmanex HFA (mometason furoate) 100 mcg/act or 200 mcg/act metered dose inhaler - Tier 2 Flovent Diskus(fluticasone propionate) 50 mcg/inhalation, 100 mcg/inhalation, or 250 mcg/inhalation dry powder inhaler - Tier 2 Flovent HFA (fluticasone propionate) 44 mcg/act, 110 mcg/act, or 220 mcg/act metered dose inhaler Tier 2 Pulmicort Flexhaler (budesonide) 90 mcg/act and 180 mcg/act Tier 3 03/01/2018 Sensipar (cinacalcet) 30 mg, 60 mg, 90 mg tablets Tier change (moved from Tier 3 to Tier 4) Tier 4, PA 03/01/2018 Shingrix (zoster vaccine recombinant, adjuvanted) Formulary addition $0, QL, AL 03/01/2018 timolol maleate (generic for Istalol) 0.5% ophthalmic solution (once daily) Tier change (moved from Tier 2 to Tier 3) Tier 3 timolol maleate 0.25% and 0.5% ophthalmic solution (generic for Timoptic) - Tier 1 03/01/2018 Vyxeos (daunorubicin and cytarabine) 44 mg/100 mg for intravenous use Formulary addition MB, PA, QL 03/01/2018 Xeljanz XR (tofacitinib) 11 mg extended-release tablets, SP MPC Page 5 of 12 Updated 04/30/18
6 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 03/01/2018 Zostavax (varicella virus vaccine) PA requirement added $0, PA, QL, AL 06/01/2018 acitretin (generic for Soriatane ) 10 mg, 17.5 mg, and 25 mg capsules 06/01/2018 Afstyla [antihemophilic factor (recombinant), single chain] 250, 500, 1000, 1500, 2000, 2500, or 3000 IU 06/01/2018 alogliptin/pioglitazone (generic for Oseni) mg, mg, mg, mg, mg, mg tablets 06/01/2018 alprazolam extended- release (generic for Xanax XR) 0.5 mg, 1 mg, 2 mg, and 3 mg tablets 06/01/2018 Alunbrig (brigatinib) 90 mg and 180 mg tablets, 90 & 180 mg therapy pack QL updated Tier 4, PA, QL, SP Formulary addition MB, SP Formulary addition Tier 2, ST, QL Formulary addition Tier 3, QL 06/01/2018 aripiprazole (generic for Abilify ) 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg tablets PA requirement removed Tier change (moved from Tier 4 to Tier 1) Tier 1, QL 06/01/2018 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) mg tablets Formulary addition Tier 4, QL MPC Page 6 of 12 Updated 04/30/18
7 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Bosulif (bosutinib) 100 mg, 400 mg, 500 mg tablets Formulary addition (400 mg tablet) PA requirements updated Tier 4, PA, QL, SP 06/01/2018 Cabometyx (cabozantinib) 20 mg, 40 mg, and 20 mg tablets 06/01/2018 celecoxib (generic for Celebrex ) 50 mg, 100 mg, 200 mg, and 400 mg capsules 06/01/2018 Cimetidine oral solution 300 mg/5 ml 06/01/2018 Cinvanti (aprepitant) 130 mg/18 ml injectable emulsion 06/01/2018 clindamycin 1% topical gel and lotion (generic for Cleocin T ) PA requirements updated Tier 4, PA, QL, SP Tier change (moved from Tier 3 to Tier 1) Tier 1, QL Tier change (moved from Tier 1 to Tier 2) Tier 2 cimetidine 200 mg, 300 mg, 400 mg and 800 mg oral tablets Tier 1 famotidine 20 mg and 40 mg oral tablets Tier 1 ranitidine 15 mg/ml, 75 mg/5 ml and 150 mg/10 ml oral syrup Tier 1 randitidine 150 mg and 300 mg oral tablets Tier 1 Formulary addition MB, PA QL added Tier 1, QL 06/01/2018 Cough and cold medications containing codeine or hydrocodone AL added Cough and cold medications containing codeine or hydrocodone will not be covered for members < 18 years of age. See formulary listing for complete formulary coverage information for cough and cold medications containing codeine or hydrocodone. MPC Page 7 of 12 Updated 04/30/18
8 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Codeine containing medications used for the treatment of pain PA requirement added for members 12 to 18 years of age Codeine containing medications are not covered for members < 12 years of age. PA required for patients 12 to 18 years of age. See formulary for complete formulary coverage information for codeine containing medications. 06/01/2018 duloxetine (generic for Cymbalta ) 60 mg capsules 06/01/2018 Eloctate [antihemophilic factor (recombinant), Fc fusion protein] 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 5000, and 6000 IU 06/01/2018 Enbrel Mini (etanercept) for injection 50 mg/ml single-dose prefilled cartridge for use with the AutoTouch reusable auto injector only QL updated Tier 1, QL Formulary removal Non-formulary Nuwiq [antihemophilic factor (recombinant)], 250, 500, 1000, 2000, 2500, 3000 and 4000 IU - MB, SP, SP 06/01/2018 enoxaparin (generic for Lovenox ) 30 mg/0.3 ml, 40 mg/0.4 ml, 60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1 ml, 120 mg/0.8 ml, and 150 mg/1 ml prefilled syringes PA requirement added for quantities exceeding plan quantity limits Tier 1, QL* *PA required for amounts exceeding QL 06/01/2018 Erleada (apalutamide) 60 mg tablets MPC Page 8 of 12 Updated 04/30/18
9 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Granix (tbo-filgrastim) 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes 06/01/2018 Iclusig (ponatinib) 15 mg and 45 mg tablets 06/01/2018 Imbruvica (ibrutinib) 140 mg, 280 mg, 420 mg and 560 mg tablets packaged as a 4-week supply 06/01/2018 Imfinzi (durvalumab) injection for intravenous use, 120/2.4 ml and 500 mg/10 ml solution in a single-dose vial 06/01/2018 Isentress (raltegravir) 100 mg chewable tablets 06/01/2018 Kalydeco (ivacaftor) 150 mg tablets; 50 mg and 75 mg oral granules 06/01/2018 Kovaltry [antihemophilic factor (recombinant)] 250, 500, 1000, 2000, and 3000 IU 06/01/2018 lidocaine 5% transdermal patch (generic for Lidoderm ) Formulary removal Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA PA requirements updated Tier 4, PA, QL, SP Formulary addition MB, PA QL updated Tier 2, QL, SP Formulary addition MB, SP PA requirement removed Tier 3, QL 06/01/2018 Nebupent (pentamadine isethionate) inhalation powder for solution 300 mg/ml Tier change (moved from Tier 1 to Tier 3) Tier 3, QL, SP MPC Page 9 of 12 Updated 04/30/18
10 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Neupogen (filgrastim) injection 300 mcg/0.5 ml and 480 mcg/0.8 ml 06/01/2018 Nuvaring (ethinyl estradiol/etonogestrel) mg vaginal ring 06/01/2018 Nuwiq [antihemophilic factor (recombinant)] 250, 500, 1000, 2000, 2500, 3000 and 4000 IU 06/01/2018 Orkambi (lumacaftor/ivacaftor) mg tablets Formulary removal Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA AL added $0, ST, QL, AL (maximum age: 55 years) Formulary addition MB, SP, SP 06/01/2018 Paxil (paroxetine) 10 mg/5 ml oral suspension PA requirement added QL added Tier change (moved from Tier 2 to Tier 3) Tier 3, PA, QL 06/01/2018 sevelamer (generic for Renvela ) 800 mg tablet 06/01/2018 Sprycel (dasatinib) 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg tablets 06/01/2018 Symdeko (tezacaftor/ivacaftor tablets; ivacaftor tablets) mg and 150 mg tablets Tier change (moved from Tier 1 to Tier 4) Tier 4 PA requirements updated Tier 4, PA, QL, SP, SP 06/01/2018 Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate) mg tablets Formulary addition Tier 4, QL MPC Page 10 of 12 Updated 04/30/18
11 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Tasigna (nilotinib) 150 mg and 200 mg capsules PA requirements updated Tier 4, PA, QL, SP 06/01/2018 Tramadol containing medications PA requirement added for members 12 to 18 years of age Tramadol containing medications are not covered for members < 12 years of age. PA required for patients 12 to 18 years of age. See formulary for complete coverage information for tramadol containing medications. 06/01/2018 Trogarzo (ibalizumab-uiyk) injection, for intravenous use 200 mg/1.33 ml in a single dose vial 06/01/2018 vancomycin (generic for Vancocin ) 125 mg capsules 06/01/2018 vancomycin (generic for Vancocin ) 250 mg capsules 06/01/2018 Verzenio (abemaciclib) 50 mg, 100 mg, 150 mg, and 200 mg tablets. 06/01/2018 Xgeva (denosumab) injection for subcutaneous use, 120 mg/1.7 ml (70 mg/ml) solution in a single-dose vial Formulary addition MB from PA to ST Tier 3, ST, QL metronidazole 500 mg tablets Tier 1 PA requirements updated Tier 3, PA, QL metronidazole 500 mg tablets Tier 1 PA requirements updated MB, PA, SP 06/01/2018 Xifaxan (rifaxamin) 200 mg and 550 mg tablets PA requirements updated Tier 4, PA, QL MPC Page 11 of 12 Updated 04/30/18
12 Drug Name Description of Formulary Coverage Formulary Alternative(s) and Tier (if applicable 06/01/2018 Xigduo XR (dapagliflozin/metformin) mg, mg, mg, mg, and mg tablets Formulary addition Tier 2, ST, QL 06/01/2018 Xulane (norelgestromin/ethinyl estradiol) 150/35 mcg/day patch AL added $0, ST, QL, AL (maximum age: 55 years) Learn more about Presbyterian s Nondiscrimination Notice and Interpreter Services. MPC Page 12 of 12 Updated 04/30/18
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent
More informationDrug Name Description of Change Formulary Coverage Formulary Alternative(s)
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Centennial Care Formulary effective 2018. For the most recent list of drugs, information on asking for a prior
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update SECOND QUARTER 2018 P&T Committee Decisions Effective June 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
More informationNOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More information2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
More informationSeptember 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to UCare (approved drug list). These changes are reviewed based
More informationELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)
ELEVATE Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) P&T/Formulary Committee Actions 4Q 2017 (Effective January 1, 2018) Marketplace Standard
More informationMercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
More informationYou ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.
3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs
More informationHealth Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More information2014 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT
More informationJANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.
ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET
More informationQuarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50
More informationSuperior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationKansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria
APREPITANT Kansas Health Advantage (HMO SNP) 2018 Formulary Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL
More informationDuring non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day.
MEICARE AVANTAGE BlueCross BlueShield of Western New York 2018 Formulary Update BlueCross BlueShield of Western New York has updated its formulary (drug list) since its original publication in January
More informationJanuary 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
More informationMemorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
More informationAPREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More informationQuarterly pharmacy formulary change notice
Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee
More informationReason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More informationHealth Partners Medicare Special Formulary Updates
March 2018 Effective Date Brand Name Generic Name Type of Change 90 / 30 DAYS tenofovir disoproxil fumarate tenofovir disoproxil fumarate clobetasol propionate tenofovir disoproxil fumarate Previous Value
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationAdded, Removed or Changed. Added, Removed or Changed
One mission: you s March 8, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your
More informationPeach State Health Plan routinely reviews the medications available on the Preferred Drug
Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationAlprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
More informationPPHP 2017 Formulary 2017 Step Therapy Criteria
ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationUPHP Advantage (HMO) (H ) and UPHP Choice (HMO) (H ) Updates
March, 2018 03/01/2018 clindacin p clindamycin phosphate 03/01/2018 glatiramer acetate 03/01/2018 glatiramer acetate 03/01/2018 oseltamivir phosphate 03/01/2018 oseltamivir phosphate 03/01/2018 ADACEL
More informationAcyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2018 P&T Committee Decisions Effective September 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationY0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18
Step Therapy Grid Certain cost-effective drugs must be used before other more expensive drugs are covered. For example, certain brand-name medications will only be covered if a generic alternative has
More informationAetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
More informationQuarterly pharmacy formulary change
Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and
More informationThe following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.
Q4 MHS PDL Changes Provider Notice The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Table 1: Summary of Medicaid PDL Additions
More informationFIRST QUARTER 2018 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES
FIRST QUARTER 2018 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES Following is the First Quarter 2018 update to the Highmark Drug Formularies and pharmaceutical management procedures. The formularies
More informationQuarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationTABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
More informationMercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
More informationHEALTH SHARE/PROVIDENCE (OHP)
HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More information5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
More information5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective January 1, 2019 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
More informationMedicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
More informationQuarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.
More informationRelative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More information2019 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationBlueLink TPA FlexRx Updates
BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%
More information2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
More informationARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.
ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882
More informationPartners Notice of Change March 2017
New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationRationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)
BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of
More informationAlameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: April 21, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
More informationWellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
More informationFormulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary
One mission: you Changes July 1, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for
More informationP&T/Formulary Committee Actions (1Q18)
P&T/Formulary Committee s (1Q18) 1Q2018 Marketplace Standard (HIEx) Additions and/or Revisions effective: April 1, 2018 Deletions effective: April 1, 2018 for NEW member prescriptions; July 1, 2018 for
More informationOregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What
More informationStep Therapy Medications
Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on
More informationQuarterly pharmacy formulary change notice
Serving Hoosier Healthwise, Healthy Indiana Plan and Hoosier Care Connect May 2018 Quarterly pharmacy formulary change notice Effective May 1, 2018, the preferred formulary changes detailed in the table
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationEFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS
EFFECTIVE 01/04/2019 pimecrolimus 1 % cream (g) - ST Added: TOPICAL IMMUNOMODULATORS PAGE 1 LAST UPDATED 03/2019 EFFECTIVE 01/05/2019 LORBRENA 100 MG TABLET lorlatinib LORBRENA 25 MG TABLET lorlatinib
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
More informationMedicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
More informationMedicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective Jan. 1, 2019 Traditional Three-Tier PDL Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our fourth-quarter Pharmacy and Therapeutics Committee meeting. Provider
More informationSan Francisco Health Plan (SFHP)
San Francisco Health Plan (SFHP) The following changes to SFHP formulary and prior authorization criteria were reviewed and approved by the SFHP Pharmacy and Therapeutics (P&T) Committee on 04/18/2018.
More informationEmblem Medicaid 3Q18 Formulary Updates
ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More information